CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 214 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54 | -91.8% | 2,000 | -93.8% | 0.00% | -100.0% |
| Q4 2022 | $658 | -99.9% | 32,400 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $830,000 | +115.6% | 32,400 | +65.3% | 0.00% | +300.0% |
| Q3 2021 | $385,000 | -33.2% | 19,600 | -25.2% | 0.00% | -50.0% |
| Q2 2021 | $576,000 | +2.3% | 26,200 | +10.5% | 0.00% | 0.0% |
| Q1 2021 | $563,000 | -9.0% | 23,700 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $619,000 | +4661.5% | 23,700 | +2862.5% | 0.00% | – |
| Q2 2020 | $13,000 | +44.4% | 800 | 0.0% | 0.00% | – |
| Q1 2020 | $9,000 | 0.0% | 800 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | – | 800 | – | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2018 | $627,000 | -37.3% | 39,900 | -34.4% | 0.00% | -25.0% |
| Q1 2018 | $1,000,000 | -8.9% | 60,800 | 0.0% | 0.00% | -20.0% |
| Q4 2017 | $1,098,000 | -2.6% | 60,800 | +4.1% | 0.01% | 0.0% |
| Q3 2017 | $1,127,000 | +31.0% | 58,400 | -19.9% | 0.01% | +25.0% |
| Q2 2017 | $860,000 | +9.8% | 72,900 | +2.0% | 0.00% | +33.3% |
| Q1 2017 | $783,000 | +16.0% | 71,500 | -23.1% | 0.00% | 0.0% |
| Q4 2016 | $675,000 | – | 93,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,188,417 | $85,349,000 | 7.80% |
| TANAKA CAPITAL MANAGEMENT INC | 144,602 | $2,379,000 | 5.69% |
| INGALLS & SNYDER LLC | 6,817,540 | $112,149,000 | 5.47% |
| NEXTHERA CAPITAL LP | 1,045,196 | $17,193,000 | 2.83% |
| Timpani Capital Management LLC | 245,279 | $4,035,000 | 1.41% |
| S&T BANK/PA | 426,257 | $7,012,000 | 1.25% |
| SHAKER INVESTMENTS LLC/OH | 107,670 | $1,771,000 | 1.10% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 434,624 | $7,150,000 | 0.94% |
| AMI ASSET MANAGEMENT CORP | 709,300 | $11,668,000 | 0.83% |
| Birchview Capital, LP | 75,500 | $1,242,000 | 0.82% |